Sophonsri A, Le D, Lou M, Ny P, Minejima E, Chambliss A
Crit Care Explor. 2024; 4(9):e0760.
PMID: 38371947
PMC: 10871785.
DOI: 10.1097/CCE.0000000000000760.
Kang S, Onishi S, Ling Z, Inoue H, Zhang Y, Chang H
Proc Natl Acad Sci U S A. 2024; 121(2):e2315898120.
PMID: 38165930
PMC: 10786312.
DOI: 10.1073/pnas.2315898120.
Ghaempanah F, Nikouei M, Cheraghi M, Jahangiri A, Moradi Y
J Pharm Policy Pract. 2023; 16(1):151.
PMID: 37986199
PMC: 10658795.
DOI: 10.1186/s40545-023-00662-w.
de Haan L, Ten Wolde M, Beudel M, Olde Engberink R, Appelman B, Haspels-Hogervorst E
BMJ Open. 2023; 13(11):e075232.
PMID: 37963704
PMC: 10649520.
DOI: 10.1136/bmjopen-2023-075232.
Bonelli M, Kerschbaumer A, Kastrati K, Ghoreschi K, Gadina M, Heinz L
Ann Rheum Dis. 2023; 83(2):139-160.
PMID: 37923366
PMC: 10850682.
DOI: 10.1136/ard-2023-223850.
Immunophenotypes of anti-SARS-CoV-2 responses associated with fatal COVID-19.
Selb J, Biteznik B, Bidovec Stojkovic U, Rituper B, Osolnik K, Kopac P
ERJ Open Res. 2022; 8(4).
PMID: 36474964
PMC: 9510901.
DOI: 10.1183/23120541.00216-2022.
Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis.
Cherian J, Eerike M, Bagepally B, Das S, Panda S
Front Pharmacol. 2022; 13:1004308.
PMID: 36330085
PMC: 9624173.
DOI: 10.3389/fphar.2022.1004308.
COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress.
Modemann F, Ghandili S, Schmiedel S, Weisel K, Bokemeyer C, Fiedler W
Cancers (Basel). 2022; 14(15).
PMID: 35954374
PMC: 9367547.
DOI: 10.3390/cancers14153711.
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
Rodrigues L, Bento Cunha R, Vassilevskaia T, Viveiros M, Cunha C
Molecules. 2022; 27(9).
PMID: 35566073
PMC: 9099573.
DOI: 10.3390/molecules27092723.
Characteristics and Outcomes of Patients With Frailty Admitted to ICU With Coronavirus Disease 2019: An Individual Patient Data Meta-Analysis.
Subramaniam A, Anstey C, Curtis J, Ashwin S, Ponnapa Reddy M, Aliberti M
Crit Care Explor. 2022; 4(1):e0616.
PMID: 35072081
PMC: 8769107.
DOI: 10.1097/CCE.0000000000000616.
Pharmacological treatment of COVID-19: an opinion paper.
Garcia-Lledo A, Gomez-Pavon J, Gonzalez Del Castillo J, Hernandez-Sampelayo T, Martin-Delgado M, Martin Sanchez F
Rev Esp Quimioter. 2021; 35(2):115-130.
PMID: 34894208
PMC: 8972693.
DOI: 10.37201/req/158.2021.
ESCMID COVID-19 living guidelines: drug treatment and clinical management.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R
Clin Microbiol Infect. 2021; 28(2):222-238.
PMID: 34823008
PMC: 8606314.
DOI: 10.1016/j.cmi.2021.11.007.
Scientific evidence in the COVID-19 treatment: A comprehensive review.
Iturricastillo G, Perez-Urria E, Counago F, Landete P
World J Virol. 2021; 10(5):217-228.
PMID: 34631473
PMC: 8474978.
DOI: 10.5501/wjv.v10.i5.217.
Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: A retrospective study of 835 patients.
Akama-Garren E, Li J
J Med Virol. 2021; 93(10):5768-5776.
PMID: 34042195
PMC: 8242482.
DOI: 10.1002/jmv.27105.
Obesity and its impact on COVID-19.
de Leeuw A, Oude Luttikhuis M, Wellen A, Muller C, Calkhoven C
J Mol Med (Berl). 2021; 99(7):899-915.
PMID: 33824998
PMC: 8023779.
DOI: 10.1007/s00109-021-02072-4.
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina N
Res Sq. 2021; .
PMID: 33619476
PMC: 7899470.
DOI: 10.21203/rs.3.rs-235272/v1.
